Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Ethan Basch, Deborah Schrag, Bryce B. Reeve et al.|JNCI Journal of the National Cancer Institute|2014Cited by 1.1k
Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Amylou C. Dueck, Ethan Basch, Tito R. Mendoza et al.|JAMA Oncology|2015Cited by 1k
Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048)Ethan Basch, Deborah Schrag, Amylou C. Dueck et al.|Journal of Clinical Oncology|2023Cited by 136
Racial/ethnic differences in clinical trial enrollment, refusal rates, ineligibility, and reasons for decline among patients at sites in the National Cancer Institute's Community Cancer Centers ProgramAisha T. Langford, Ronald S. Go, Kathy Wilkinson et al.|Cancer|2013Cited by 134